Answers are grounded in this paper and cite their sources.
This analysis highlights the limitations of the right to refuse treatment under the Life-Sustaining Treatment Decision Act, suggesting reforms to enhance patient autonomy.
This paper examines the significance of the right to refuse treatment as a constitutional right, addressing the issue that this right is not sufficiently guaranteed in Korea. The right to refuse treatment is rooted in the principle of informed consent, which ensures that all patients can make autonomous and informed decisions about their healthcare. Although Korean courts acknowledge the right to refuse treatment based on the right to self-determination enshrined in Article 10 of the Constitution, they restrict its application to specific circumstances, thus undermining the practical protection of patients' rights. In Western, particularly Anglo-American legal systems, the right to refuse treatment has long been recognized as a legal right, with its scope and implications evolving through case law and legislation. Internationally, this right is actively safeguarded by international norms and national medical ethics codes. In contrast, Korean discussions on the right to refuse treatment have largely been limited to specific situations, such as the refusal of blood transfusions or life-sustaining treatments, without broader application in medical practice. The Life-Sustaining Treatment Decision Act, enacted in 2016, establishes procedures and methods for withdrawing or withholding life-sustaining treatment. However, it does not adequately ensure patients' right to refuse such treatment autonomously. Instead, the law restricts this right to specific circumstances and methods, significantly narrowing its scope and meaning. In this context, a broader discussion on the constitutional right to refuse treatment is crucial to safeguarding patient autonomy in Korea. Moreover, there is a pressing need to create a medical environment that fully upholds patients' constitutional rights. The Life-Sustaining Treatment Decision Act should be revised to reflect this direction, and legal and institutional mechanisms must be established to actively protect patients' general right to refuse treatment.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: